Post-genomic Approaches in Drug and Vaccine Development PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Post-genomic Approaches in Drug and Vaccine Development PDF full book. Access full book title Post-genomic Approaches in Drug and Vaccine Development by Kishore R. Sakharkar. Download full books in PDF and EPUB format.
Author: Kishore R. Sakharkar
Publisher: CRC Press
ISBN: 1000795713
Category : Science
Languages : en
Pages : 451
Get Book Here
Book Description
Over the past decade, genome sequencing projects and the associated efforts have facilitated the discovery of several novel disease targets and the approval of several innovative drugs. To further exploit this data for human health and disease, there is a need to understand the genome data itself in detail, discover novel targets, understand their role in physiological pathways and associated diseases, with the aim to translate these discoveries to clinical and preventive medicine. It is equally important to understand the labors and limitations in integrating clinical phenotypes with genomic, transcriptomic, proteomic and metabolomic approaches. T
Author: Kishore R. Sakharkar
Publisher: River Publishers
ISBN: 8793102844
Category : Medical
Languages : en
Pages : 451
Get Book Here
Book Description
Over the past decade, genome sequencing projects and the associated efforts have facilitated the discovery of several novel disease targets and the approval of several innovative drugs. To further exploit this data for human health and disease, there is a need to understand the genome data itself in detail, discover novel targets, understand their role in physiological pathways and associated diseases, with the aim to translate these discoveries to clinical and preventive medicine. It is equally important to understand the labors and limitations in integrating clinical phenotypes with genomic, transcriptomic, proteomic and metabolomic approaches. This book focuses on some key advances in the field. Technical topics discussed in the book include: Drug discoveryTarget identification and prioritizationHypothesis driven multi-target drug designGenomics in vaccine developmentGene regulatory networks Vaccine design and developmentPrediction of drug side effects in silico
Author: Kishore R. Sakharkar
Publisher: CRC Press
ISBN: 1000795713
Category : Science
Languages : en
Pages : 451
Get Book Here
Book Description
Over the past decade, genome sequencing projects and the associated efforts have facilitated the discovery of several novel disease targets and the approval of several innovative drugs. To further exploit this data for human health and disease, there is a need to understand the genome data itself in detail, discover novel targets, understand their role in physiological pathways and associated diseases, with the aim to translate these discoveries to clinical and preventive medicine. It is equally important to understand the labors and limitations in integrating clinical phenotypes with genomic, transcriptomic, proteomic and metabolomic approaches. T
Author: Chiranjib Chakraborty
Publisher: Daya Books
ISBN: 9788176221054
Category : DNA microarrays
Languages : en
Pages : 264
Get Book Here
Book Description
The World Needs Various Sustainable New Drugs. Are We Really Heading Fast Enough In The Right Direction? Without A Strong And Committed Move Towards Proper Direction, Many More New Problems Will Crop Up, Which Will Solve Through Modern Biotechnology And Bioinformatics. This Book Will Be A Landmark For The Students, Researchers And Professionals Of Pharmaceutical Industry Who Are Really Trying For New Drug Development. This Book Is A Compilation Of Different Aspects Like Molecular Engineering Of Protein For New Drugs. Dna Chips Preparation, Genomic Image Processing For Development Of New Drugs, Dna Vaccination, Combo-Vaccination, Gene Therapy And Some Other Modern Topics Related To New Drug Discovery With The Biotechnology And Bioinformatics. Contents Chapter 1: Dna Chips Technology For Implementation Of Genomic Drugs; Chapter 2: New Dna Vaccines: Another Milestone For Pharmaceutical Industry; Chapter 3: Plasmid Dna Preparation: An Approach Towards New Dna Vaccine Development; Chapter 4: Molecular (Protein And Non-Protein) Engineering For Designing Of New Drugs; Chapter 5: Bacterial Adhesins-Based Surface Protein: Today S Target For New Vaccine Development; Chapter 6: Development For Malaria New Vaccine: A New Possibility For The World, Chapter 7: Computer Aided Drug Designing; Chapter 8: Genomic Image Processing And Analysis For Development Of New Genomic Medicine; Chapter 9: Development Of Combo-Vaccine: A New Trend; Chapter 10: Chromatography: The Most Effective Technique For Development Of New Herbal Medicine; Chapter 11: Transgenic Technology: Modern Factories For Synthesis Of New Molecule; Chapter 12: Clinical Trials: The Ultimate Testing Ground; Chapter 13: Gene Therapy: A Revolutionary Development In Medicine; Chapter 14: Liposomes As Drug Delivery System For Biotechnological Drugs; Chapter 15: Stem Cell: A New Therapeutic Approach; Chapter 16: Antibody Engineering And Recombinant Monoclonal Antibodies For Development Of New Drugs; Chapter 17: Recombinant Dna Technology For Development Of Recombinant Therapeutic Proteins As New Drugs; Appendix I: Approved Biotechnology Drugs 2002; Appendix Ii: Biotech Company Products Approved By The Fda In 2000; Appendix Iii: Biotech Products Under Fda Review; Appendix Iv: Biotechnology Drugs For Cancer Diagnosis And Therapy.
Author: Diego Oliva
Publisher: Springer Nature
ISBN: 3030697444
Category : Technology & Engineering
Languages : en
Pages : 594
Get Book Here
Book Description
This book presents a compilation of the most recent implementation of artificial intelligence methods for solving different problems generated by the COVID-19. The problems addressed came from different fields and not only from medicine. The information contained in the book explores different areas of machine and deep learning, advanced image processing, computational intelligence, IoT, robotics and automation, optimization, mathematical modeling, neural networks, information technology, big data, data processing, data mining, and likewise. Moreover, the chapters include the theory and methodologies used to provide an overview of applying these tools to the useful contribution to help to face the emerging disaster. The book is primarily intended for researchers, decision makers, practitioners, and readers interested in these subject matters. The book is useful also as rich case studies and project proposals for postgraduate courses in those specializations.
Author: National Research Council
Publisher: National Academies Press
ISBN: 0309075556
Category : Science
Languages : en
Pages : 118
Get Book Here
Book Description
This report surveys opportunities for future Army applications in biotechnology, including sensors, electronics and computers, materials, logistics, and medical therapeutics, by matching commercial trends and developments with enduring Army requirements. Several biotechnology areas are identified as important for the Army to exploit, either by direct funding of research or by indirect influence of commercial sources, to achieve significant gains in combat effectiveness before 2025.
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309219396
Category : Science
Languages : en
Pages : 570
Get Book Here
Book Description
Many potential applications of synthetic and systems biology are relevant to the challenges associated with the detection, surveillance, and responses to emerging and re-emerging infectious diseases. On March 14 and 15, 2011, the Institute of Medicine's (IOM's) Forum on Microbial Threats convened a public workshop in Washington, DC, to explore the current state of the science of synthetic biology, including its dependency on systems biology; discussed the different approaches that scientists are taking to engineer, or reengineer, biological systems; and discussed how the tools and approaches of synthetic and systems biology were being applied to mitigate the risks associated with emerging infectious diseases. The Science and Applications of Synthetic and Systems Biology is organized into sections as a topic-by-topic distillation of the presentations and discussions that took place at the workshop. Its purpose is to present information from relevant experience, to delineate a range of pivotal issues and their respective challenges, and to offer differing perspectives on the topic as discussed and described by the workshop participants. This report also includes a collection of individually authored papers and commentary.
Author: Kishore R. Sakharkar
Publisher: CRC Press
ISBN: 1000794873
Category : Health & Fitness
Languages : en
Pages : 385
Get Book Here
Book Description
Understanding the molecular mechanisms of cancer is the key for transforming cancer medicine. A substantial proportion of human genes show alternative splicing and mis-regulation of Pre-mRNA splicing is seen in several cancers.This book further investigates these matters. The first few chapters provide an update on the role of genomics in understanding alternative splicing, and targets in cancer pathogenesis. Advances and prospects in applications of nanotechnology for cancer prevention, detection and treatment are a promising field of research. The subsequent chapters provide insights on how nanotechnology-based therapeutics are moving towards revolutionizing cancer and infectious disease treatment by minimizing toxicity and facilitating targeted delivery of drugs. Technical topics discussed in the book include: • Alternative splicing and cancer• Cancer imaging• Nanomaterials in infectious diseases• Nanomedicine in oxidative stress and cancer• Nanoparticle based drug delivery systems
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309498511
Category : Medical
Languages : en
Pages : 103
Get Book Here
Book Description
To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Author: Darren R. Flower
Publisher: Springer Science & Business Media
ISBN: 1461450705
Category : Medical
Languages : en
Pages : 316
Get Book Here
Book Description
This volume will address an important emergent area within the field of immunomics: the discovery of antigens and adjuvants within the context of reverse vaccinology. Conventional approaches to vaccine design and development requires pathogens to be cultivated in the laboratory and the immunogenic molecules within them to be identifiable. Conventional vaccinology is no longer universally successful, particularly for recalcitrant pathogens. By using genomic information we can study vaccine development in silico: 'reverse vaccinology', can identify candidate subunits vaccines by identifying antigenic proteins and by using equally rational approaches to identify novel immune response-enhancing adjuvants.
Author: National Research Council
Publisher: National Academies Press
ISBN: 0309180716
Category : Science
Languages : en
Pages : 102
Get Book Here
Book Description
The U.S. Department of Energy (DOE) promotes scientific and technological innovation to advance the national, economic, and energy security of the United States. Recognizing the potential of microorganisms to offer new energy alternatives and remediate environmental contamination, DOE initiated the Genomes to Life program, now called Genomics: GTL, in 2000. The program aims to develop a predictive understanding of microbial systems that can be used to engineer systems for bioenergy production and environmental remediation, and to understand carbon cycling and sequestration. This report provides an evaluation of the program and its infrastructure plan. Overall, the report finds that GTL's research has resulted in and promises to deliver many more scientific advancements that contribute to the achievement of DOE's goals. However, the DOE's current plan for building four independent facilities for protein production, molecular imaging, proteome analysis, and systems biology sequentially may not be the most cost-effective, efficient, and scientifically optimal way to provide this infrastructure. As an alternative, the report suggests constructing up to four institute-like facilities, each of which integrates the capabilities of all four of the originally planned facility types and focuses on one or two of DOE's mission goals. The alternative infrastructure plan could have an especially high ratio of scientific benefit to cost because the need for technology will be directly tied to the biology goals of the program.
